STOCK TITAN

Camtek Ltd Form 4 Filings

CAMT NASDAQ

Every Form 4 that Camtek Ltd (CAMT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CAMT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CAMT filings page.

Rhea-AI Summary

CAMTEK LTD officer Orit Geva-Dvash, Vice President of HR, reported selling 508 Ordinary Shares of CAMT on 2026-08-17 in an open market or private transaction at $175.00 per share. Following this sale, she directly holds 5,205 Ordinary Shares. The Rule 10b5-1 trading-plan checkbox was not marked as used.

Rhea-AI Summary

CAMTEK LTD director Andorn Karni Yarl reported option exercises and share sales in August 2026. On August 14, stock options for 3,176 Ordinary Shares at an exercise price of $22.63 per share were exercised and the resulting shares were sold at $164.40 per share. On August 13, options for 880 shares at $63.51 were exercised and the resulting shares were sold in multiple transactions, including 880 shares at $172.7428 and 1,476 shares at a weighted average price of $172.1221 per share, with detailed price ranges disclosed in a footnote. The options and underlying shares referenced in certain transactions were exercised and sold on the same dates.

Rhea-AI Summary

Camtek Ltd (CAMT) Chief Operating Officer Ram Langer reported a sale of 6,387 Ordinary Shares on 2026-08-13 in an open-market or private transaction. The shares were sold at a weighted average price of $172.3222 per share, with individual trade prices ranging from $172.13 to $172.72. Following this transaction, Langer directly holds 17,532 Ordinary Shares. The transaction was not reported as made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

CAMTEK LTD Chief Executive Officer Rafi Amit reported selling 6,250 Ordinary Shares of CAMT on 2026-08-13 in a sale classified as an open market or private transaction at a price of $170.52 per share. Following this transaction, he directly holds 55,350 Ordinary Shares. The sale was not marked as being made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

CAMTEK LTD vice president of HR, Orit Geva-Dvash, reported a sale of 415 Ordinary Shares of CAMT on 2026-08-12 at $174.0623 per share in an open-market or private transaction. Following this sale, she directly holds 5,713 Ordinary Shares, a balance that includes one additional share previously omitted from her Form 3 due to a rounding error. The filing does not indicate that this trade was made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

Camtek Ltd (CAMT) director Aviram Lior reported selling a total of 6,694 ordinary shares in four open-market transactions on August 11–12, 2026, at prices between 162.0000 and 175.0000 per share. The Rule 10b5-1 checkbox was not selected. A footnote explains that one additional share had been omitted from a prior Form 3 due to a rounding error.

Rhea-AI Summary

Camtek Ltd. Chief Financial Officer Moshe Eisenberg reported open-market sales of Camtek ordinary shares. On 2026-08-12 he sold 645 shares at $172.6717 per share. On 2026-08-11 he sold 3,759 shares at a weighted average price of $160.0561, in multiple trades between $160.00 and $160.5651 per share.

Rhea-AI Summary

Camtek Ltd director Shacham Yosef reported equity awards on July 29, 2026. He received 254 restricted stock units, each representing a contingent right to one ordinary share, and 571 stock options with a 147.87 per-share exercise price expiring July 29, 2033. Both awards vest at Camtek's 2027 annual shareholders meeting, and he now directly holds 6,734 ordinary shares plus 571 options.

Rhea-AI Summary

Camtek Ltd director Andorn Karni Yarl reported equity-based compensation awards. He received 254 restricted stock units, each representing one Ordinary Share, vesting at the Company’s 2027 annual meeting of shareholders subject to continued service, and 571 stock options with a $147.87 exercise price, also vesting at that meeting and expiring on July 29, 2033. Following the RSU award, he directly owns 2,819 Ordinary Shares.

Rhea-AI Summary

Stav Orit reported acquisition or exercise transactions in this Form 4 filing.

Camtek Ltd director Orit Stav received equity-based compensation consisting of 254 restricted stock units, each representing one ordinary share, and 571 stock options to buy ordinary shares at $147.8700 per share. Both the RSUs and options vest at the Company’s 2027 annual shareholder meeting, subject to continued service, and the options expire on July 29, 2033. After these awards, Stav is reported to hold 2,819 ordinary shares directly.

Rhea-AI Summary

Camtek Ltd director Ben Arie Mordechay reported equity compensation awards dated July 29, 2026. He received 254 restricted stock units, each representing one ordinary share, and a grant of 571 stock options with a $147.8700 exercise price expiring on 2033-07-29. Both the RSUs and options vest on the date of the Company's 2027 annual meeting of shareholders, subject to his continued service.